Glazer Capital LLC’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,000
| Closed | -$10K | – | 518 |
|
|
2022
Q4 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 470 |
|
|
2022
Q3 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 635 |
|
|
2022
Q2 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 645 |
|
|
2022
Q1 | $10K | Buy |
+1,000
| New | +$10K | ﹤0.01% | 514 |
|
|
2021
Q4 | – | Sell |
-211,064
| Closed | -$2.11M | – | 996 |
|
|
2021
Q3 | $2.11M | Sell |
211,064
-14,296
| -6% | -$143K | 0.04% | 394 |
|
|
2021
Q2 | $2.27M | Sell |
225,360
-125,988
| -36% | -$1.27M | 0.04% | 419 |
|
|
2021
Q1 | $3.46M | Buy |
+351,348
| New | +$3.46M | 0.05% | 389 |
|